Linezolid Dosing for a 35 kg Female
A 35 kg female should receive linezolid 600 mg PO/IV every 12 hours (BID), as this patient falls into the adult dosing category based on weight and age considerations.
Dosing Algorithm
The appropriate linezolid dose depends on whether this patient is classified as pediatric or adult:
Age-Based Classification
If the patient is ≥12 years old:
- Dose: 600 mg PO/IV every 12 hours 1
- This is the standard adult dose regardless of the 35 kg body weight
- The IDSA guidelines explicitly state that pediatric patients 12 years and older should receive the adult dose of 600 mg BID 1
If the patient is <12 years old:
- Dose: 10 mg/kg PO/IV every 8 hours, not to exceed 600 mg/dose 1
- For a 35 kg patient: 350 mg every 8 hours (total daily dose: 1,050 mg/day)
- This pediatric dosing achieves similar daily AUC values to the adult BID regimen 2
Pharmacokinetic Rationale
The distinction between pediatric and adult dosing is based on clearance differences:
- Pediatric patients (birth to 11 years) have more rapid linezolid clearance, resulting in lower single-dose systemic exposure and shorter half-life compared to adults 2
- Adolescents (≥12 years) have clearance values that approach adult levels, justifying the transition to adult dosing 2
- The every-8-hour pediatric regimen compensates for faster clearance to achieve therapeutic drug exposure equivalent to the adult every-12-hour regimen 2
Critical Considerations
No Weight-Based Adjustment for Adults
Unlike many antibiotics, linezolid dosing in adults is NOT adjusted for body weight 1, 2. The standard 600 mg BID dose applies regardless of whether the patient weighs 35 kg or 100 kg, provided they are ≥12 years old.
Renal Function
No dose adjustment is required for renal insufficiency regarding the parent drug 2. However, metabolites may accumulate in severe renal impairment. If the patient requires hemodialysis, administer linezolid after dialysis sessions 2.
Monitoring Requirements
- Monitor for thrombocytopenia, particularly if treatment extends beyond 2 weeks
- Target trough concentrations should remain <8 mg/L to minimize toxicity risk 3, 4
- For serious infections with MIC ≥2 mg/L, therapeutic drug monitoring may be warranted to ensure AUC24/MIC ratio ≥100 5
Common Pitfall
The most common error would be attempting to reduce the adult dose proportionally based on the 35 kg weight. This is incorrect. Once a patient reaches 12 years of age, they receive the full adult dose of 600 mg BID, regardless of body weight being below typical adult ranges 1, 2.